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INTRODUCTION
Hypoparathyroidism leads to hypocalcemia, hyperphosphatemia, and elevated frac-
tional excretion of calcium in the urine, due to either absent or inadequately low circu-
lating concentrations of parathyroid hormone (PTH). Conventional therapy of
hypoparathyroidism consists of oral calcium and activated vitamin D or vitamin D
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KEY POINTS
 Conventional therapy of hypoparathyroidism consists of oral calcium and activated
vitamin D or vitamin D supplements at doses adjusted to meet the needs of the patient.
 Therapeutic goals are to prevent symptoms and signs of hypocalcemia; to maintain low
normal calcium and normal phosphate levels and a calcium-phosphate product less
than 55 mg2/dL2; and to avoid hypercalciuria, hypercalcemia, and end-organ complica-
tions such as renal and other extraskeletal calcifications.
 Calcium carbonate is better absorbed at a low gastric pH level achieved at meal times.
Calcium citrate is a better choice for patients taking proton pump inhibitors or H2 agonists
and can be taken with or without meals.
 Calcitriol or alfacalcidol, both activated forms of vitamin D, are considered the treatments
of choice for most patients with hypoparathyroidism.
 Diets rich in calcium may reduce the amount of calcium supplements needed, but
phosphate intake needs to be considered carefully.
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